Pacira Biosciences, Inc. (PCRX)
25.12
+0.26
(+1.05%)
USD |
NASDAQ |
Aug 25, 12:58
Pacira Biosciences Shareholders Equity (Quarterly) : 671.98M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 671.98M |
| March 31, 2026 | 653.89M |
| December 31, 2025 | 693.11M |
| September 30, 2025 | 727.21M |
| June 30, 2025 | 757.77M |
| March 31, 2025 | 798.54M |
| December 31, 2024 | 778.35M |
| September 30, 2024 | 749.58M |
| June 30, 2024 | 879.28M |
| March 31, 2024 | 892.16M |
| December 31, 2023 | 870.13M |
| September 30, 2023 | 831.55M |
| June 30, 2023 | 807.98M |
| March 31, 2023 | 768.04M |
| December 31, 2022 | 775.01M |
| September 30, 2022 | 770.12M |
| June 30, 2022 | 756.64M |
| March 31, 2022 | 709.58M |
| December 31, 2021 | 730.41M |
| September 30, 2021 | 718.60M |
| June 30, 2021 | 687.17M |
| March 31, 2021 | 650.82M |
| December 31, 2020 | 619.69M |
| September 30, 2020 | 584.69M |
| June 30, 2020 | 388.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 374.04M |
| December 31, 2019 | 354.94M |
| September 30, 2019 | 346.16M |
| June 30, 2019 | 341.65M |
| March 31, 2019 | 327.52M |
| December 31, 2018 | 321.23M |
| September 30, 2018 | 301.27M |
| June 30, 2018 | 290.51M |
| March 31, 2018 | 278.52M |
| December 31, 2017 | 279.48M |
| September 30, 2017 | 264.80M |
| June 30, 2017 | 261.05M |
| March 31, 2017 | 270.63M |
| December 31, 2016 | 218.98M |
| September 30, 2016 | 214.15M |
| June 30, 2016 | 228.35M |
| March 31, 2016 | 226.17M |
| December 31, 2015 | 218.39M |
| September 30, 2015 | 209.01M |
| June 30, 2015 | 195.28M |
| March 31, 2015 | 184.02M |
| December 31, 2014 | 171.14M |
| September 30, 2014 | 155.07M |
| June 30, 2014 | 147.97M |
| March 31, 2014 | 35.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | 12.62B |
| Liquidia Corp. | 195.11M |
| Johnson & Johnson | 84.97B |
| Merck & Co., Inc. | 41.93B |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.244B |
| Total Liabilities (Quarterly) | 572.00M |
| Debt to Equity Ratio | 0.6133 |
| Current Ratio | 5.042 |
| Net Debt Paydown Yield | 4.44% |